Genentech delves into apps to link with breast cancer patients

Over years of cancer drug research, Genentech Inc. has kept a keen watch on patients: how they respond to drugs in a clinical trial, for example, or what patients need in a next-generation drug. Yet even as the South San Francisco-based biotech unit of Swiss drug giant Roche developed some of the best-selling and effective cancer drugs — Avastin and Herceptin among them — it heard from patients that the medications themselves were not enough. Breast cancer patients, in particular, wanted to…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news